Biotherapeutics announced that Northwestern University/Northwestern Memorial Hospital is starting recruitment for the CLD-101 ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, ...

UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...

UroGen Pharma (NASDAQ:URGN) stock in focus as company acquires oncolytic virus ICVB-1042 from IconOVir Bio, to design ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...

UroGen Pharma (URGN) announced expansion of its oncology pipeline portfolio through the acquisition of assets relating to a next-generation ...

Fintel reports that on February 20, 2025, Citigroup initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a Buy ...

It’s hard to say something nice about viruses, but Dr. Joaquín Martínez Martínez can. Dr. Martínez Martínez is a new aquatic ...

The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and clinical advancements, ...